betamethasone 6 MG/ML Injectable Suspension [Betavet]
- RxCUI
- 1660750
- RxNorm name
- betamethasone 6 MG/ML Injectable Suspension [Betavet]
- Term type
- SBD
- Status
- Active
- Updated
- 2026-10-20 20:49:32
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 092015
- Active start
- 092015
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
Ingredient, Strength, Base table| Ingredient | Strength | Base | Basis of strength |
|---|
| betamethasone | 6 MG / 1 ML | betamethasone | betamethasone |
Derived Ingredient Concepts#
RxNav Current And Historical NDCs#
RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.
NDC11, Source, Active table| NDC11 | Source | Active |
|---|
| 10797072001 | rxnav_ndcs | yes |
UNII Substances#
UNII substance links page 1 of 1 · 0 matching rows.
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|
| 3eb6b1d3-4485-4b25-aaab-92de9b2fb322 | BetaVet 6 MG/ML Injectable Suspension [PSN] · betamethasone 6 MG/ML Injectable Suspension [Betavet] [SBD] · Betavet 6 MG/ML Injectable Suspension [SY] | 3 | 12 | BETAVET ® (Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension) | 20241007 |
Recently Linked DailyMed Labels#
Set ID, Title, Manufacturer table| Set ID | Title | Manufacturer | Effective |
|---|
| 3eb6b1d3-4485-4b25-aaab-92de9b2fb322 | BETAVET ® (Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension) | American Regent, Inc. | 20241007 |
| 3eb6b1d3-4485-4b25-aaab-92de9b2fb322 | BETAVET ® (Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension) | American Regent, Inc. | 20241007 |
Drug Classes#
Source, Class ID, Class table| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|
| ATC | C05AA | Corticosteroids | ATC1-4 | | betamethasone |
| ATC | S03BA | Corticosteroids | ATC1-4 | | betamethasone |
| ATC | S02BA | Corticosteroids | ATC1-4 | | betamethasone |
| ATC | R01AD | Corticosteroids | ATC1-4 | | betamethasone |
| ATC | A07EA | Corticosteroids acting locally | ATC1-4 | | betamethasone |
| ATC | S01BA | Corticosteroids, plain | ATC1-4 | | betamethasone |
| ATC | D07AC | Corticosteroids, potent (group III) | ATC1-4 | | betamethasone |
| ATC | D07XC | Corticosteroids, potent, other combinations | ATC1-4 | | betamethasone |
| ATC | S01CB | Corticosteroids/antiinfectives/mydriatics in combination | ATC1-4 | | betamethasone |
| ATC | R03BA | Glucocorticoids | ATC1-4 | | betamethasone |
| ATC | H02AB | Glucocorticoids | ATC1-4 | | betamethasone |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | betamethasone |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | betamethasone |
| MEDRT | D001623 | Betamethasone | CHEM | has_ingredient | betamethasone |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | betamethasone |
| MEDRT | D012628 | Dermatitis, Seborrheic | DISEASE | may_treat | betamethasone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | betamethasone |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | betamethasone |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | betamethasone |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | betamethasone |
| MEDRT | D011565 | Psoriasis | DISEASE | may_treat | betamethasone |
| MEDRT | D016553 | Purpura, Thrombocytopenic, Idiopathic | DISEASE | ci_with | betamethasone |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | betamethasone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | betamethasone |
| MEDRT | N0000008297 | Antipruritic Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | betamethasone |
| MEDRT | N0000009928 | Decreased Cellular Migration | PE | has_pe | betamethasone |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | betamethasone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008700 | Decreased Lysosomal Function | PE | has_pe | betamethasone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | betamethasone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | betamethasone |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | betamethasone |
Properties#
Category, Property, Value table| Category | Property | Value |
|---|
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | RXNAV_VET_DRUG | US |
| ATTRIBUTES | VET_DRUG | US |
| CODES | NADA | NADA141418 |
| NAMES | Prescribable Synonym | BetaVet 6 MG/ML Injectable Suspension |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |